Abnormal Vaginal Discharge
Evidence-Based Diagnostic and Management Approach
Department of Obstetrics and Gynecology
Prof. Mykhailo Medvediev
Understanding Vaginal Discharge
Abnormal vaginal discharge is one of the most common gynecological complaints, affecting millions of women worldwide. It may result from infectious or noninfectious etiologies and requires systematic evaluation to ensure accurate diagnosis and appropriate treatment.
The normal vaginal flora, predominantly lactobacilli, maintains pH levels between 4.0-4.5, preventing overgrowth of pathogenic organisms. Disruption of this delicate ecosystem can lead to various infectious and inflammatory conditions.

Clinical Pearl: Not all vaginal discharge is pathological. Physiologic leukorrhea is normal when discharge is nonmalodorous and without pruritus or irritation.
Reference: CDC Sexually Transmitted Infections Treatment Guidelines, 2021
Key Points in Clinical Assessment
Most Common Causes
Bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis account for the majority of infectious cases
Other Infectious Causes
Gonorrhea, chlamydia, Mycoplasma genitalium, and occasionally aerobic vaginitis
Noninfectious Causes
Atrophic changes (genitourinary syndrome of menopause), allergic or mechanical irritation
Reference: ACOG Practice Bulletin on Vaginitis, 2020
Initial Clinical Evaluation
Essential Components
  • Thorough sexual history
  • Comprehensive gynecologic history
  • Speculum examination
  • Pregnancy test for all reproductive-age patients
Assessment Focus
Evaluate color, consistency, amount, and odor of discharge. Assess associated symptoms including itching, burning, dyspareunia, and bleeding.
Perform speculum examination to observe discharge characteristics and inspect the cervix for inflammation, friability, or lesions suggestive of cervicitis or malignancy.
Reference: WHO Guidelines for the Management of Sexually Transmitted Infections, 2021
Key Diagnostic Tests
01
Vaginal pH Measurement
Normal pH 4.0-4.5; elevated pH >4.5 suggests bacterial vaginosis, trichomoniasis, or aerobic vaginitis
02
Amine (Whiff) Test
Fishy odor upon adding KOH indicates bacterial vaginosis or trichomoniasis
03
Wet Mount Microscopy
Identifies motile trichomonads, clue cells, yeast, or white blood cells
04
NAAT for STIs
Nucleic acid amplification testing for N. gonorrhoeae, C. trachomatis, and T. vaginalis
Reference: IUSTI European Guidelines on Vaginal Discharge, 2018
Bacterial Vaginosis: Overview
22-50%
Prevalence
Most common cause of abnormal vaginal discharge
4.5+
Vaginal pH
Elevated above normal range
3/4
Amsel Criteria
Required for clinical diagnosis
Bacterial vaginosis is a polymicrobial dysbiosis characterized by overgrowth of Gardnerella vaginalis and other anaerobes, with decreased concentrations of protective Lactobacillus acidophilus. This condition does not cause epithelial inflammation because there is no immune response.
Reference: CDC STI Treatment Guidelines, 2021
Bacterial Vaginosis: Clinical Features
Typical Presentation
  • Gray or milky vaginal discharge
  • Characteristic fishy odor
  • Vaginal pH > 4.5
  • Often asymptomatic
"Pruritus and pain are uncommon in bacterial vaginosis, helping distinguish it from other causes of discharge."
Risk Factors
  • Sexual intercourse (primary risk factor)
  • Intrauterine devices
  • Vaginal douching
  • Pregnancy
  • Uncircumcised male partner
Reference: British Association for Sexual Health and HIV Guidelines, 2022
Bacterial Vaginosis: Amsel Criteria
1
Clue Cells
Vaginal epithelial cells with stippled appearance and fuzzy borders due to bacteria adhering to cell surface, identified on wet mount
2
Vaginal pH > 4.5
Elevated pH measurement above normal vaginal range
3
Positive Whiff Test
Fishy amine odor when 10% potassium hydroxide is added to vaginal discharge sample
4
Characteristic Discharge
Thin, homogeneous gray-white or yellow discharge adhering to vaginal walls

Diagnostic Mnemonic - DAMP: Discharge (gray/milky), Amine odor (positive whiff test), Microscopy (clue cells), pH > 4.5
Reference: Amsel et al., American Journal of Medicine, 1983
Bacterial Vaginosis: Treatment
First-Line Therapy
Oral metronidazole 500 mg twice daily for 7 days
OR Intravaginal metronidazole gel 0.75% once daily for 5 days
OR Intravaginal clindamycin cream 2% once daily for 7 days
Alternative Options
Oral clindamycin 300 mg twice daily for 7 days (safe in pregnancy)
Oral tinidazole 2 g once daily for 2 days (nonpregnant only)
Oral secnidazole 2 g single dose (nonpregnant only)
Recurrent Infection
Consider alternative agents, longer treatment duration, or suppressive therapy with intravaginal metronidazole
May treat male partners in recurrent cases
Reference: CDC Sexually Transmitted Infections Treatment Guidelines, 2021
Vulvovaginal Candidiasis: Overview
17-39%
Prevalence
Second most common cause of vulvovaginitis
90%
Candida albicans
Primary causative organism
4.0-4.5
Normal pH
Vaginal pH remains in normal range
Vulvovaginal candidiasis results from overgrowth of Candida albicans, primarily affecting immunocompetent women. In immunosuppressed patients, Candida glabrata may also be responsible. The condition is characterized by thick, white discharge and intense pruritus.
Reference: ACOG Practice Bulletin on Vulvovaginal Candidiasis, 2020
Vulvovaginal Candidiasis: Risk Factors
Pregnancy
Hormonal changes and altered immune response increase susceptibility to candidal overgrowth
Immune Deficiency
Poorly controlled diabetes mellitus, HIV infection, or immunosuppressive therapy
Antimicrobial Treatment
Systemic antibiotic use disrupts normal vaginal flora, allowing yeast overgrowth
Corticosteroid Use
Both systemic and topical corticosteroids can predispose to candidal infection
Reference: European Academy of Dermatology and Venereology Guidelines, 2020
Vulvovaginal Candidiasis: Clinical Features
Characteristic Symptoms
  • White, crumbly, sticky discharge resembling cottage cheese
  • Typically odorless
  • Erythematous vulva and vagina
  • Severe pruritus (itching)
  • Vaginal burning sensation
  • Dysuria (painful urination)
  • Dyspareunia (painful intercourse)

Key Distinguishing Feature: Normal vaginal pH (4.0-4.5) helps differentiate candidiasis from bacterial vaginosis and trichomoniasis
Reference: International Union against Sexually Transmitted Infections Guidelines, 2021
Vulvovaginal Candidiasis: Classification
1
Uncomplicated VVC
Sporadic or infrequent episodes, mild-to-moderate symptoms, caused by C. albicans, in immunocompetent women
2
Complicated VVC
Recurrent infection (≥3 episodes/year), severe symptoms, non-albicans species, or presence of diabetes/immunosuppression
Obtain vaginal culture in all patients with complicated vulvovaginal candidiasis to identify causative organism and guide treatment.
Reference: CDC Sexually Transmitted Infections Treatment Guidelines, 2021
Vulvovaginal Candidiasis: Treatment
Uncomplicated - Nonpregnant
Topical azole: Miconazole or clotrimazole intravaginally for 1-7 days
OR Oral fluconazole: 150 mg single dose (adults only)
Uncomplicated - Pregnant
Topical azole only: 7-day course of miconazole or clotrimazole intravaginally
Note: Oral fluconazole is NOT recommended in pregnancy due to risk of spontaneous abortion and fetal malformations
Complicated VVC
Extended therapy: 7-14 days of topical azole OR oral fluconazole every 72 hours for 3 doses
Suppressive maintenance: Oral fluconazole 150 mg weekly for 6 months for recurrent infection
Reference: ACOG Practice Bulletin No. 215, 2020
Trichomoniasis: Overview
Epidemiology & Pathogen
Trichomoniasis accounts for 4-35% of vaginal discharge cases. The causative organism is Trichomonas vaginalis, an anaerobic, motile protozoan with flagella.
This organism does not form cysts and therefore does not survive well outside the human body, making sexual transmission the primary route of infection.
Key Characteristics
  • Sexually transmitted infection
  • Foul-smelling, frothy discharge
  • Yellow-green coloration
  • Vaginal pH > 4.5
  • Strawberry cervix appearance

Mnemonic: "After sex, Burn the Foul, Green Tree" - Burning sensation and foul-smelling, yellow-green discharge are features of trichomoniasis
Reference: WHO Guidelines for the Management of Sexually Transmitted Infections, 2021
Trichomoniasis: Diagnosis & Treatment
1
Initial Testing
Saline vaginal wet mount showing motile trophozoites with multiple flagella. Vaginal pH > 4.5
2
Confirmatory Tests
If wet mount inconclusive, perform culture or NAAT for definitive diagnosis
3
Treatment
Oral metronidazole 500 mg twice daily for 7 days OR tinidazole 2 g single dose
4
Partner Treatment
Concurrent treatment of all sexual partners essential to prevent reinfection
5
Follow-up
Screen for repeat infection after 3 months. Test for other STIs
Reference: CDC Sexually Transmitted Infections Treatment Guidelines, 2021
Diagnostic Workflow: Point-of-Care Testing
Multiplex NAAT vaginal panels can simultaneously detect bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis with significantly higher accuracy than traditional wet mount or Amsel criteria. This improved diagnostic accuracy reduces misdiagnosis and inappropriate therapy.
Reference: Journal of Clinical Microbiology, Comparative Study of Diagnostic Methods, 2020
Comprehensive Diagnostic Algorithm
A systematic approach to diagnosis substantially improves accuracy and reduces inappropriate antibiotic use. Empiric treatment based solely on symptoms risks misdiagnosis. Laboratory testing should guide therapeutic decisions whenever possible.
Reference: IUSTI European Guidelines on Vaginal Discharge Management, 2018
Differential Diagnosis Table
Reference: American Family Physician, Evaluation of Vaginal Discharge, 2019
Aerobic Vaginitis
Key Features
Noninfectious microbiome disturbance with secondary bacterial overgrowth
Vaginal pH > 4.5
Leukocytosis on microscopy
Yellow, odorless discharge
Causative Organisms
  • Escherichia coli (gram-negative)
  • Streptococcus agalactiae (gram-positive)
  • Enterococcus faecalis (gram-positive)
Treatment Approach
Antibiotics targeting aerobic bacteria, local steroids, and local estrogens may be beneficial. Culture-guided therapy is recommended.
Reference: Journal of Lower Genital Tract Disease, Aerobic Vaginitis Review, 2019
Noninfectious Causes of Vaginal Discharge
Genitourinary Syndrome of Menopause
Low estrogen levels cause atrophy of vaginal and vulvar epithelium. Presents with vaginal dryness, soreness, dyspareunia, and urinary symptoms. Treatment includes moisturizers, lubricants, and local or systemic estrogen therapy.
Allergic Vulvovaginitis
Contact allergy triggered by irritants, soaps, detergents, or latex. Presents with pruritus, burning, and signs of inflammation. Management includes avoiding irritants, moisturizers, cooling measures, and cortisone creams.
Mechanical Vulvovaginitis
Caused by friction from tight clothing, excessive exercise, or sexual activity. Common in postmenopausal women with lichen sclerosis. Treatment is cause-specific with moisturizers and cooling measures.
Reference: North American Menopause Society Position Statement, 2020
Complications of Untreated Infections
Pregnancy Complications
Preterm delivery, spontaneous abortion, postpartum endometritis, intrauterine growth restriction
Increased STI Risk
Higher susceptibility to acquiring sexually transmitted infections, including HIV
Recurrent Infection
Inadequate treatment or reinfection from untreated partners leads to chronic symptoms
Pelvic Inflammatory Disease
Ascending infection can cause PID, chronic pelvic pain, and infertility
Reference: Sexually Transmitted Infections Journal, Complications Review, 2021
Clinical Pearls for Practice
Avoid Empiric Treatment
Empiric treatment based solely on symptoms risks misdiagnosis and inappropriate therapy. Laboratory testing substantially improves diagnostic accuracy and treatment outcomes.
Consider Mixed Infections
Mixed infections (e.g., bacterial vaginosis with Candida or Trichomonas) are common. Comprehensive testing reduces recurrence and antibiotic misuse.
Partner Treatment Matters
For trichomoniasis and recurrent bacterial vaginosis, concurrent partner treatment is essential to prevent reinfection and treatment failure.
Culture When Needed
Obtain vaginal culture in complicated cases, treatment failures, and when non-albicans Candida species are suspected to guide targeted therapy.
Reference: Best Practice Guidelines from Multiple International Societies, 2020-2022
Prevention and Patient Education
Preventive Measures
  • Avoid vaginal douching
  • Use condoms consistently
  • Wear breathable cotton underwear
  • Avoid prolonged use of wet clothing
  • Limit use of scented products
  • Maintain good glycemic control if diabetic
  • Complete full course of antibiotics when prescribed
When to Seek Care
  • Change in discharge color, odor, or amount
  • Vaginal itching or burning
  • Painful urination or intercourse
  • Vaginal bleeding between periods
  • Lower abdominal pain
  • Symptoms persisting after treatment
Reference: Patient Education Materials from ACOG and CDC, 2021
Summary and Key Takeaways
1
Systematic Evaluation is Essential
Thorough history, physical examination, and appropriate laboratory testing are crucial for accurate diagnosis and effective treatment of abnormal vaginal discharge.
2
Know the Common Causes
Bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis account for the majority of cases. Each has distinct clinical and laboratory features.
3
Use Evidence-Based Diagnostics
pH testing, wet mount microscopy, and NAAT provide complementary information. Multiplex panels offer superior accuracy for simultaneous detection.
4
Tailor Treatment Appropriately
Consider pregnancy status, severity, recurrence, and causative organism when selecting therapy. Treat partners when indicated to prevent reinfection.
Department of Obstetrics and Gynecology
Prof. Mykhailo Medvediev
References: CDC STI Treatment Guidelines 2021, ACOG Practice Bulletins 2020-2022, WHO Guidelines 2021, IUSTI European Guidelines 2018-2022